Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 25 studies | 34% ± 15% | |
| fibroblast | 16 studies | 30% ± 15% | |
| smooth muscle cell | 15 studies | 26% ± 9% | |
| pericyte | 14 studies | 27% ± 13% | |
| astrocyte | 13 studies | 41% ± 17% | |
| macrophage | 11 studies | 36% ± 13% | |
| microglial cell | 11 studies | 35% ± 11% | |
| oligodendrocyte | 11 studies | 37% ± 12% | |
| GABAergic neuron | 10 studies | 43% ± 25% | |
| glutamatergic neuron | 10 studies | 47% ± 26% | |
| oligodendrocyte precursor cell | 10 studies | 39% ± 16% | |
| adipocyte | 9 studies | 38% ± 10% | |
| epithelial cell | 8 studies | 40% ± 20% | |
| myeloid cell | 7 studies | 26% ± 7% | |
| ciliated cell | 7 studies | 31% ± 9% | |
| basal cell | 7 studies | 34% ± 22% | |
| neuron | 6 studies | 44% ± 20% | |
| endothelial cell of lymphatic vessel | 6 studies | 40% ± 15% | |
| type I pneumocyte | 6 studies | 32% ± 13% | |
| interneuron | 5 studies | 55% ± 23% | |
| B cell | 5 studies | 24% ± 8% | |
| retina horizontal cell | 5 studies | 30% ± 13% | |
| retinal cone cell | 5 studies | 24% ± 8% | |
| cardiac muscle cell | 5 studies | 35% ± 9% | |
| mast cell | 5 studies | 24% ± 8% | |
| monocyte | 5 studies | 31% ± 6% | |
| club cell | 5 studies | 31% ± 11% | |
| type II pneumocyte | 5 studies | 33% ± 9% | |
| hepatocyte | 4 studies | 60% ± 30% | |
| granule cell | 4 studies | 29% ± 5% | |
| dendritic cell | 4 studies | 23% ± 3% | |
| mesothelial cell | 4 studies | 28% ± 6% | |
| lymphocyte | 4 studies | 29% ± 13% | |
| amacrine cell | 4 studies | 28% ± 10% | |
| retinal rod cell | 4 studies | 27% ± 7% | |
| respiratory goblet cell | 4 studies | 37% ± 11% | |
| glial cell | 3 studies | 25% ± 5% | |
| progenitor cell | 3 studies | 28% ± 2% | |
| plasma cell | 3 studies | 31% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 0% | |
| vein endothelial cell | 3 studies | 40% ± 22% | |
| retinal bipolar neuron | 3 studies | 24% ± 7% | |
| Mueller cell | 3 studies | 37% ± 10% | |
| retinal ganglion cell | 3 studies | 35% ± 14% | |
| endothelial cell of vascular tree | 3 studies | 35% ± 23% | |
| cholangiocyte | 3 studies | 60% ± 16% | |
| connective tissue cell | 3 studies | 25% ± 6% | |
| adventitial cell | 3 studies | 21% ± 7% | |
| myofibroblast cell | 3 studies | 35% ± 10% | |
| T cell | 3 studies | 24% ± 3% | |
| alveolar macrophage | 3 studies | 42% ± 11% | |
| capillary endothelial cell | 3 studies | 25% ± 5% | |
| chondrocyte | 3 studies | 29% ± 9% | |
| natural killer cell | 3 studies | 22% ± 2% | |
| muscle cell | 3 studies | 42% ± 30% | |
| mucus secreting cell | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2280.38 | 1445 / 1445 | 100% | 27.43 | 183 / 183 |
| lung | 100% | 1820.73 | 577 / 578 | 100% | 25.38 | 1155 / 1155 |
| ovary | 100% | 1658.28 | 180 / 180 | 100% | 15.09 | 429 / 430 |
| brain | 100% | 1401.66 | 2635 / 2642 | 100% | 18.38 | 705 / 705 |
| breast | 100% | 2040.52 | 459 / 459 | 100% | 28.41 | 1113 / 1118 |
| prostate | 100% | 1972.09 | 245 / 245 | 99% | 23.20 | 498 / 502 |
| intestine | 100% | 2276.27 | 966 / 966 | 99% | 16.23 | 522 / 527 |
| stomach | 100% | 1441.61 | 359 / 359 | 99% | 16.27 | 282 / 286 |
| kidney | 100% | 1310.84 | 89 / 89 | 98% | 19.20 | 887 / 901 |
| uterus | 100% | 2175.54 | 170 / 170 | 98% | 21.96 | 451 / 459 |
| bladder | 100% | 2285.67 | 21 / 21 | 98% | 17.09 | 495 / 504 |
| thymus | 100% | 1843.44 | 653 / 653 | 98% | 17.84 | 594 / 605 |
| adrenal gland | 100% | 1848.07 | 258 / 258 | 97% | 17.48 | 224 / 230 |
| pancreas | 99% | 931.28 | 326 / 328 | 98% | 20.68 | 174 / 178 |
| liver | 100% | 1800.90 | 226 / 226 | 95% | 11.71 | 385 / 406 |
| skin | 100% | 1772.81 | 1808 / 1809 | 93% | 16.55 | 441 / 472 |
| adipose | 100% | 2189.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2444.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3795.48 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1651.18 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 18.87 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.53 | 1 / 1 |
| heart | 98% | 1527.02 | 840 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 9.30 | 24 / 29 |
| eye | 0% | 0 | 0 / 0 | 70% | 9.38 | 56 / 80 |
| peripheral blood | 61% | 589.47 | 563 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032355 | Biological process | response to estradiol |
| GO_0033147 | Biological process | negative regulation of intracellular estrogen receptor signaling pathway |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0035331 | Biological process | negative regulation of hippo signaling |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0090443 | Cellular component | FAR/SIN/STRIPAK complex |
| GO_0030425 | Cellular component | dendrite |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_0051721 | Molecular function | protein phosphatase 2A binding |
| GO_0005516 | Molecular function | calmodulin binding |
| GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0031267 | Molecular function | small GTPase binding |
| GO_0070016 | Molecular function | armadillo repeat domain binding |
| Gene name | STRN3 |
| Protein name | Striatin 3 Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen) Striatin, calmodulin binding protein 3 (cDNA FLJ77970, highly similar to Homo sapiens nuclear autoantigen GS2NA mRNA) |
| Synonyms | SG2NA GS2NA |
| Description | FUNCTION: Binds calmodulin in a calcium dependent manner. May function as scaffolding or signaling protein. |
| Accessions | H0YJZ4 H0YJT2 ENST00000355683.9 [Q13033-2] ENST00000357479.10 [Q13033-1] ENST00000555358.5 G3V340 A0AV58 G3V3G7 ENST00000555152.1 ENST00000556577.1 Q13033 ENST00000554991.5 |